Edap Tms (NASDAQ:EDAP) Lifted to "Hold" at Zacks Investment Research
Edap Tms (NASDAQ:EDAP – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market […]